GlassScriptPhysician profile
Benjamin L Taylor
NPI 1437410339
$36,769.85
in general payments reported to CMS, 2019-2025
47 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $4,543 · 2021: $210 · 2022: $1,833 · 2023: $1,357 · 2024: $18K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21K · Food and Beverage: $4,884 · Travel and Lodging: $4,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,750.00 |
| Food and Beverage | $4,883.88 |
| Travel and Lodging | $4,097.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,541.99 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $4,220.91 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $1,516.39 | 2019-2023 | Provenge |
| Janssen Biotech, INC. | $1,122.16 | 2019-2025 | Erleada, Akeega, Balversa |
| Progenics Pharmaceuticals, INC. | $429.62 | 2023-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $381.88 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Sumitomo Pharma America, INC. | $344.79 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $339.22 | 2019-2023 | Myrbetriq |
| Urogen Pharma, INC. | $316.35 | 2022-2024 | Jelmyto |
| Boston Scientific Corporation | $283.97 | 2019-2023 | |
| Immunitybio, INC. | $192.62 | 2024-2025 | |
| Procept Biorobotics Corporation | $171.44 | 2022 | |
| Ferring Pharmaceuticals INC. | $158.28 | 2024 | Adstiladrin |
| Medtronic, INC. | $151.11 | 2021-2024 | Interstim |
| Pfizer INC. | $146.49 | 2019-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $122.11 | 2025 | Cvac Aspiration System |
| Coloplast Corp | $119.91 | 2025 | |
| Olympus America INC. | $102.90 | 2025 | Soltive, Itind System |
| Edap Technomed INC | $100.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $90.45 | 2024-2025 | |
| Urovant Sciences INC | $70.52 | 2022 | |
| Abbvie INC. | $70.30 | 2023-2025 | Lupron Depot |
| Hollister Incorporated | $64.73 | 2022-2024 | Vapro Pocket, Infyna Chic |
| Ethicon US, LLC | $57.83 | 2020-2025 | Echelon Flex |
| Myriad Genetic Laboratories, INC. | $55.81 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $53.60 | 2024-2025 | |
| Myovant Sciences INC. | $48.79 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $46.26 | 2020-2024 | Xiaflex |
| 180 Medical, INC. | $42.75 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $41.97 | 2022-2024 | Opdivo |
| Antares Pharma, INC. | $33.46 | 2025 | Xyosted |
| Astrazeneca Pharmaceuticals LP | $31.12 | 2021 | |
| Photocure INC | $30.01 | 2023 | Cysview |
| Zyla Life Sciences, INC. | $28.57 | 2020 | |
| Telix Pharmaceuticals | $27.56 | 2023-2024 | Illuccix |
| Laborie Medical Technologies Corp. | $25.85 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Angiodynamics, INC. | $25.79 | 2023 | Nanoknife |
| Corcept Therapeutics | $19.50 | 2024 | Korlym |
| Tolmar, INC. | $18.84 | 2025 | Eligard, Jatenzo |
| Teleflex LLC | $18.05 | 2025 | Urolift |
| Blue Earth Diagnostics | $16.76 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $16.16 | 2025 | Bard Urinary Drainage Bag |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2022 | |
| Eisai INC. | $14.83 | 2019 | |
| Acerus Pharmaceuticals Corporation | $14.80 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $14.65 | 2019 | |
| Axonics, INC. | $13.75 | 2023 | Axonics, Bulkamid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.